StockWatch
·

BAFNA PHARMACEUTICALS LTD. Q2 FY27 Results

BAFNAPHQ2 FY27 Results
Filing
Result:Very Good· Market: Flat#Margin expansion#Record quarter
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue47.6779.3%34.4%
Total Income48.8071.3%33.2%
Expenditure41.9547.6%25.1%
PBT6.859018.8%119.2%
Net Profit6.859018.8%119.2%
OPM18.05%14.73pp5.98pp
NPM14.03%13.77pp5.50pp
EPS2.899533.3%118.9%
View full financials

Revenue +34.4% YoY and adjusted PAT +119% YoY with genuine OPM expansion (12.1%→18.1%) and NPM expansion (8.5%→14.0%) driven by operating leverage on the core business, marking a 6-quarter high in both revenue and PAT — a clear standout for a small-cap pharma, with no estimate available to judge street beat/miss.

Q2 FY-2027 RESULTS · BAFNAPH

Bafna Pharma Q2 FY27: PAT doubles YoY to ₹6.85 Cr on margin expansion, revenue +34%

PAT +119.1% YoY · revenue +34.4% · margins expanding

11 Nov 2026 · 3 min read
Revenue

₹47.67 Cr

+34.4% YoY

PAT (standalone)

₹6.85 Cr

+119.1% YoY

Net margin

14.04%

+5.5pp YoY

EPS

₹2.89

Bafna Pharmaceuticals reported standalone Q2 FY27 (quarter ended September 30, 2026) revenue of ₹47.67 Cr, up 34.4% YoY from ₹35.47 Cr, and net profit of ₹6.85 Cr, up 119% YoY from ₹3.12 Cr — standalone is the only basis reported, as the filing carries no consolidated statement. EPS rose to ₹2.89 from ₹1.32. Neither period carries an exceptional item, so the headline YoY growth is also the adjusted growth. Sequentially revenue rose 79.3% and profit swung from a near-breakeven ₹0.08 Cr in Q1 FY27 (a seasonal low), so the QoQ profit comparison is not meaningful off that tiny base and shouldn't be read as the story.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹47.67 Cr+79.3%+34.4%
Expenses₹41.95 Cr+47.6%+25.1%
PAT₹6.85 Cr+9019%+119.1%
Net margin14.04%+13.8pp+5.5pp
EPS₹2.89+9533.3%+118.9%

The growth came with genuine margin expansion rather than a one-off: net margin widened to 14.4% from 8.5% a year earlier, and OPM (EBITDA/revenue) widened to 18.1% from 12.1%, pointing to operating leverage on higher volumes. Separately, the company again recorded zero tax expense this quarter, so the full ₹6.85 Cr PBT flowed through to PAT — the same pattern as the year-ago quarter — worth watching for whether this is a sustained tax-shield effect or the effective rate normalizes in a future quarter.

₹
213.12288.24363.35438.46513.58484.508-1009-0109-2410-1911-11Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹484.5, up 11.8% over the past month of trading.

₹ Cr
02.565.117.673.39Q1 FY26rev ₹35 Cr3.12Q2 FY26rev ₹35 Cr1.84Q3 FY26rev ₹38 Cr2.75Q4 FY26rev ₹42 Cr0.08Q1 FY27rev ₹27 Cr6.85Q2 FY27rev ₹48 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.

There is no prior management guidance or concall commentary on record for this quarter, and a web search found no analyst or brokerage preview/consensus estimate for this micro-cap print, so the vsStreet and vsGuidance verdicts are unknown; no management press release beyond the regulatory filing was available to cross-check management's own framing of the quarter. Separately, the statutory auditor flagged (emphasis of matter, not a qualification) an ongoing GST dispute — a ₹235.47 Lakh demand under appeal and a ₹331.09 Lakh refund-recovery order stayed by the Madras High Court — management says it does not anticipate an adverse outcome and has made no provision; this sits outside the P&L for now but is a contingent liability worth tracking into subsequent quarters.

  • W1

    GST litigation outcome — ₹235.47 Lakh demand (under appeal) and ₹331.09 Lakh refund-recovery order (HC stay) — a loss would create a liability not currently provided for

  • W2

    Whether OPM (18.1% this quarter vs 12.1% a year ago) holds into Q3 FY27 or reverts toward prior-year levels

  • W3

    Effective tax rate — two straight quarters (this one and year-ago) of zero tax expense; watch if/when tax becomes payable

Informational and educational content only. Not investment advice.